Chief Technical Ops Officer of Ptc Therapeutics, Inc. (NASDAQ:PTCT), Almstead Neil Gregory, sells 502 shares worth $31,310
According to Ptc Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 07 04:54 PM, company Chief Technical Ops Officer, Almstead Neil Gregory disclosed selling 502 shares at a cost of $62.37. At the time of this transaction (Jan 05), this trade was worth $31,310 in total. As of Jan 05, Almstead Neil Gregory now owns 26,587 shares in total worth about $1,832,376.04.
For the last few recent trades made by Ptc Therapeutics, Inc. (NASDAQ:PTCT) Chief Technical Ops Officer, Almstead Neil Gregory, we have the following information:
- SEC Form 4 filing: Jan 05: Sold 124 shares at the rate of $62.37 per share. Total worth of this trade was $7,734. Total number of shares owned as of Jan 05 were 1,788
- SEC Form 4 filing: Jan 04: Sold 103,438 shares at the rate of $60.58 per share. Total worth of this trade was $6,266,167. Total number of shares owned as of Jan 04 were 27,089
- SEC Form 4 filing: Jan 04: Sold 600 shares at the rate of $60.65 per share. Total worth of this trade was $36,390. Total number of shares owned as of Jan 04 were 1,912
Posted by
George Daniels
on Thursday January 07 2021, 7:04 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
